Modular Solution for Cosmetics Compliance
Check the Conformity of your Formulas
Secure your regulatory documents for each zone
Optimize on-site risk management
Manage your Safety Data Sheets efficiently
Automate your regulatory monitoring
Ensure the traceability of your substances
Maintain good HSE risk management
Cosmetic Factory won Best Technology Application 2025. EcoMundo’s AI-powered PLM helps cosmetic brands develop faster, safer, fully compliant products worldwide.
Recevez une fois par mois les dernières actus réglementaires et conseils d’experts.
According to a report by the European Commission, the REACH, CLP and BPR regulations represent almost 1/3 of the regulatory costs that weigh on the chemical industry!
With Brexit looming, only 48% of British companies have transferred their chemical registrations to EU-27 entities, risking the availability of over 700 substances in the EU market. The uncertain political landscape adds to the urgency for companies to prepare for a no-deal scenario.
With the introduction of the harmonized format for reporting to poison control centers, a new requirement for standard information has emerged. These are the UFIs, or Unique Formula Identifier (in English). Affixed to the label, the UFI will make it easy to identify a mixture in the event of a call to poison control centers.
Learn about Current Good Manufacturing Practices (cGMP) regulations, how they ensure high quality products, and the consequences of non-compliance. Understand which parts of the manufacturing process are regulated and when products need to adhere to cGMPs.
The Korean Ministry of Environment has proposed a temporary adjustment to K-REACH regulations to address potential supply chain shortages. This includes simplified registration for new chemical substances and relaxed rules for research and development exemptions until December 2021.
CBD is permitted in cosmetics in Europe if derived from seeds or leaves without tops, while THC is banned. Regulations vary by country, with stricter rules in places like Sweden and Australia. Caution is advised in product claims, as therapeutic claims are not allowed.